IP Library Granted Patent US 12,276,658
Granted Patent B2
US 12,276,658 · App. 14/419,665 · Granted Apr 15, 2025

Compositions and methods for rapid and reversible biomolecular labeling

Inventor: Samuel Jon Clarke (Vancouver, CA)
Assignee: StemCell Technologies Canada Inc.
G01N33/533B01D15/265G01N33/54306G01N33/56966G01N33/58B82Y5/00G01N2333/7155
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,276,658
App. No.
14/419,665
Granted
Apr 15, 2025
Kind
B2
Abstract

This disclosure provides compositions and methods for a low-avidity, high-affinity and high-specificity biomolecular interaction that is rapidly reversible under physiological conditions. The methods comprise linking biological targets (such as molecules, proteins, DNA, cells, etc.) with polymers and anti-polymer ligands and a way to reverse their binding using physiologically compatible polymeric compounds. The methods also comprise a way to combine different polymer/anti-polymer systems for orthogonal labeling. The compositions comprise labels including particles (fluorescent, magnetic, dense, etc.) conjugated to polymers or labels conjugated to anti-polymer antibodies. The compositions also comprise biomolecules (proteins, antibodies, DNA, etc.) conjugated to the polymers. These methods and compositions represent a major improvement to the state-of-the-art. They are particularly useful for separation and isolation of biological targets using particles, but have important application to other fields including fluorescent imaging.

Claims (32)

1. A method of separating target cells from a label in a sample comprising:

1) Binding the target cells to the label through a linking system comprising (i) an antibody that binds to the target cells, (ii) an antibody that binds to a first polymer, and (iii) a label either conjugated with the first polymer or with the antibody that binds to the first polymer, the first polymer having a first molecular weight;

2) Separating the target cells bound to the label from the sample to enrich a first population of the target cells;

3) contacting the enriched cells of step 2) with a second polymer, the second polymer having a second molecular weight and specifically reversing the interaction between the antibody that binds to the first polymer and the first polymer, wherein a ratio of the first molecular weight and the second molecular weight is 10:1 or less; and

4) separating label from the target cells to obtain a second population of the target cells with increased cell purity compared to the first population of the target cells, wherein a percentage of the target cells in the second population is higher than a percentage of the target cells in the first population.

2. The method according to claim 1 wherein the first and second polymer have similar affinity for the ligand.

3. The method according to claim 1 wherein the first and second polymer are independently selected from PEG, PEG derivatives, poly(carboxybetaine), dextran, starch, heparin, chitin, cellulose, peptides and nucleic acids.

4. The method according to claim 1 wherein the label is selected from solid supports, fluorescent proteins and dyes, antibodies, enzymes, functional proteins, peptides or growth factors and radioactive or elemental tags.

5. The method according to claim 1 wherein the first polymer and second polymers are independently selected from PEG and PEG derivatives.

6. The method according to claim 1 wherein the label is a solid support.

7. The method according to claim 6 wherein the solid support comprises particles.

8. A method of separating target cells from a label in a sample, comprising:

1) Binding the target cells to a label through a linking system comprising (i) an antibody that binds to the target cells, (ii) an antibody that binds to a first polymer, and (iii) a label either conjugated with a first polymer or with the antibody that binds to the first polymer;

2) Separating the target cells bound to the label from the sample to enrich a first population of the target cells;

3) contacting the enriched cells of step 2) with a second polymer, the second polymer specifically reversing the interaction between the antibody that binds to the first polymer and the first polymer; and

4) separating label from the target cells to obtain a second population of recapturable target cells with increased cell purity compared to the first population of the target cells, wherein a percentage of the target cells in the second population is higher than a percentage of the target cells in the first population.

9. The method according to claim 8 wherein the first and second polymer have similar affinity for the ligand.

10. The method according to claim 8 wherein the first and second polymer are independently selected from PEG, PEG derivatives, poly(carboxybetaine), dextran, starch, heparin, chitin, cellulose, peptides and nucleic acids.

11. The method according to claim 8 wherein the label is selected from solid supports, fluorescent proteins and dyes, antibodies, enzymes, functional proteins, peptides or growth factors and radioactive or elemental tags.

12. The method according to claim 8 wherein the first polymer and second polymers are independently selected from PEG and PEG derivatives.

13. The method according to claim 8 wherein the label is a solid support.

14. The method according to claim 13 wherein the solid support comprises particles.

15. The method according to claim 1 wherein the concentration of the second polymer is between 0.0001 to 10% w/v.

16. The method according to claim 15 wherein the concentration of the second polymer is between 0.0001 5% w/v.

17. The method according to claim 1 wherein the range of the ratio of the first molecular weight and the second molecular weight is between 1:1 to 8:1.

18. The method according to claim 8 wherein the range of the ratio of a molecular weight of the first polymer and a molecular weight of the second polymer is between 1:1 to 8:1.

19. A method of separating target cells from a label in a sample comprising:

1) Binding the target cells to the label through a linking system comprising (i) an antibody that binds to the target cells, (ii) an antibody that binds to a first polymer, and (iii) a label either conjugated with the first polymer or with the antibody that binds to the first polymer;

2) Separating the target cells bound to the label from the sample to enrich a first population of the target cells;

3) contacting the enriched cells of step 2) with a second polymer, the second polymer specifically reversing the interaction between the antibody that binds to the first polymer and the first polymer; and

4) separating label from the target cells to obtain a second population of the target cells with increased cell purity compared to the first population of the target cells, wherein a percentage of the target cells in the second population is higher than a percentage of the target cells in the first population.

20. The method according to claim 16 wherein the concentration of the second polymer is between 0.001 to 5% w/v.

Assignments (2)
SECURITY INTEREST Recorded Jun 30, 2022
From: STEMCELL TECHNOLOGIES CANADA INC.
To: HSBC BANK CANADA
Reel/Frame 060544/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2015
From: CLARKE, SAMUEL JON
To: STEMCELL TECHNOLOGIES INC.
Reel/Frame 034892/0882 →
Continuity (3)
Provisional Application 61781651 · Mar 14, 2013
Provisional Application 61692422 · Aug 23, 2012
Related Publication 20150204857A1 · Jul 23, 2015
References Cited (22)
US 5017472A · Bankert · 1991 [cited by examiner]
US 5429927A · Afseth et al. · 1995 [cited by applicant]
US 5518882A · Lund · 1996 [cited by examiner]
US 5985658A · Colinas et al. · 1999 [cited by applicant]
US 7524635B2 · Buechler · 2009 [cited by examiner]
US 20020000398A1 · Skold · 2002 [cited by examiner]
US 20040186359A1 · Beaudoin et al. · 2004 [cited by applicant]
US 20050208510A1 · Latham · 2005 [cited by examiner]
US 20070004628A1 · Sung · 2007 [cited by examiner]
US 20090137064A1 · Mukumoto · 2009 [cited by applicant]
WO WO9427698A2 · 1994 [cited by examiner]
WO WO9708557A1 · 1997 [cited by examiner]
WO WO0195942A2 · 2001 [cited by applicant]
WO WO2004091494A2 · 2004 [cited by applicant]
WO WO2009127045A1 · 2009 [cited by examiner]
Anastase et al., Affinity Chromatography of human anti-dextran antibodies Isolation of two distinct populations, Journal of Chromatography B, 686, (1996), p. 141-150. [cited by examiner]
Chalmers et al., Quantification of Non-specific Binding of Magnetic Micro and Nano particles using Cell Tracking Velocimetry: Implication for magnetic cell separation and detection, Biotechnol. Bioeng., 105(6), (2010), … [cited by examiner]
Okern, G. et al. (Invitrogen), (2007) Isolation and Expansion of Mouse CD4+CD25+ Regulatory T Cells using Dynabeads® Magnetic Separation Technology. [Poster Presentation] (Year: 2007). [cited by examiner]
By Invitrogen Product Guide, Invitrogen Life Technologies, Dynabeads® FlowComp™ Human CD45RA, (2 pages), Feb. 2012, Online [http://tools.thermofisher.com/content/sfs/manuals/dynaflow_hu_CD45RA_pbmc_man.pdf], Accessed Ju… [cited by examiner]
Life Diagnostics Inc., Affinity Purification of 20kDA mPEG-BSA using anti-PEG, Product Data Sheet, Jul. 6 ,2017, Life Diagnostics Inc, West Chester, PA, USA. [cited by applicant]
Anastase, S. et al. “Affinity chromatography of human anti-dextran antibodies Isolation of two distinct populations”, Journal of Chromatography B: Biomedical Sciences and Applications, Elsevier Science Publishers, NL, v… [cited by applicant]
Sondi, I. et al., “Preparation of Aminodextran-CdS Nanoparticle Complexes and Biologically Active Antibody-Aminodextran-CdS Nanoparticle Conjugates”, Langmuir 2000, 16, 3107-3118. [cited by applicant]